JAMA Surg:双侧乳房切除术对年轻乳腺癌患者生活质量和社会心理的影响

2020-09-22 MedSci原创 MedSci原创

研究认为,对于接受双侧乳房切除术的青年乳腺癌患者,在术后身体功能、身体形象、性健康和焦虑状态异常的比例仍高于保乳手术和单侧乳房切除人群

年轻女性乳腺癌患者中,接受双侧乳房切除术(BM)的比例不断增加,但在这一人群中,手术对患者短期和长期身体和心理健康的影响研究尚不充分。近日研究人员评估了BM手术对患者生活质量(QOL)和社会心理结果的影响。

研究在北美多个医疗中心开展,2006年至2016年间,0-3期单侧乳腺癌患者参与研究,患者年龄≤40岁,患者接受了原发性乳腺手术包括保乳手术(BCS)、单侧乳房切除(UM)和BM。在手术后进行了QOL和心理社会评估。研究的主要终点为患者身体功能、身体形象、性健康、焦虑和抑郁症状,以调整后的平均分数评估,得分越高表明机能较差。

826名患者参与研究,平均确诊年龄为36.1岁,大多数为非西班牙裔白人(86.7%)。45%患者接受BM,31%接受了BCS,24%接受了UM。在接受BM/UM的女性中,84%进行了乳房重建。接受BM的患者随着时间的推移,身体机能、性行为和身体形象都有所改善,但与接受BCS的患者相比,在身体形象(第一年,1.32 vs 0.64;第五年,1.19 vs 0.48,)和性健康(第一年,1.66 vs 1.20;第五年,1.43 v s0.96)方面较差,与UM患者相比,身体形象(第1年,1.32 vs 1.15;第5年,1.19 vs 0.96)和性健康(第一年,1.66 vs 1.41;第5年,1.43 vs 1.09)方面较差。

随访的进行,各组患者的焦虑均有所改善,但在1年(BM vs BCS vs UM,7.75vs 6.94vs 6.58)、2年(7.47 vs 6.18 vs 6.07)和5年时(6.67 vs 5.91vs 5.79)随访过程中,BM组与BCS/UM相比,抑郁程度较高。

研究认为,对于接受双侧乳房切除术的青年乳腺癌患者,在术后身体功能、身体形象、性健康和焦虑状态异常的比例仍高于保乳手术和单侧乳房切除人群。

原始出处:

Shoshana M. Rosenberg et al.Association of Breast Cancer Surgery With Quality of Life and Psychosocial Well-being in Young Breast Cancer Survivors JAMA Surg. September 16, 2020.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1801498, encodeId=3392180149819, content=<a href='/topic/show?id=2dfae3977a2' target=_blank style='color:#2F92EE;'>#社会心理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73977, encryptionId=2dfae3977a2, topicName=社会心理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Apr 25 15:58:32 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769260, encodeId=ab871e692604b, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Fri Nov 13 11:58:32 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877329, encodeId=75a918e732931, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Tue Apr 27 02:58:32 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522462, encodeId=bba3152246298, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571222, encodeId=af6615e12224c, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617028, encodeId=cdfc161e028be, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887597, encodeId=615488e597a9, content=<a href='/topic/show?id=426b6109112' target=_blank style='color:#2F92EE;'>#术后管理#</a>应当重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61091, encryptionId=426b6109112, topicName=术后管理)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Sep 23 09:59:23 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887514, encodeId=74e988e514f6, content=对于接受双侧<a href='/topic/show?id=cb322362105' target=_blank style='color:#2F92EE;'>#乳房切除术#</a>的青年<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>患者,在术后身体功能、身体形象、性健康和焦虑状态异常的比例仍高于保乳手术和单侧乳房切除人群。因此,<a href='/topic/show?id=4bf12e14928' target=_blank style='color:#2F92EE;'>#保乳术#</a>仍然十分关键!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23621, encryptionId=cb322362105, topicName=乳房切除术), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌), TopicDto(id=27149, encryptionId=4bf12e14928, topicName=保乳术)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 22 22:07:17 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036277, encodeId=de7f10362e7be, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Sep 22 21:58:32 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1801498, encodeId=3392180149819, content=<a href='/topic/show?id=2dfae3977a2' target=_blank style='color:#2F92EE;'>#社会心理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73977, encryptionId=2dfae3977a2, topicName=社会心理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Apr 25 15:58:32 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769260, encodeId=ab871e692604b, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Fri Nov 13 11:58:32 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877329, encodeId=75a918e732931, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Tue Apr 27 02:58:32 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522462, encodeId=bba3152246298, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571222, encodeId=af6615e12224c, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617028, encodeId=cdfc161e028be, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887597, encodeId=615488e597a9, content=<a href='/topic/show?id=426b6109112' target=_blank style='color:#2F92EE;'>#术后管理#</a>应当重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61091, encryptionId=426b6109112, topicName=术后管理)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Sep 23 09:59:23 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887514, encodeId=74e988e514f6, content=对于接受双侧<a href='/topic/show?id=cb322362105' target=_blank style='color:#2F92EE;'>#乳房切除术#</a>的青年<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>患者,在术后身体功能、身体形象、性健康和焦虑状态异常的比例仍高于保乳手术和单侧乳房切除人群。因此,<a href='/topic/show?id=4bf12e14928' target=_blank style='color:#2F92EE;'>#保乳术#</a>仍然十分关键!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23621, encryptionId=cb322362105, topicName=乳房切除术), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌), TopicDto(id=27149, encryptionId=4bf12e14928, topicName=保乳术)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 22 22:07:17 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036277, encodeId=de7f10362e7be, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Sep 22 21:58:32 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1801498, encodeId=3392180149819, content=<a href='/topic/show?id=2dfae3977a2' target=_blank style='color:#2F92EE;'>#社会心理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73977, encryptionId=2dfae3977a2, topicName=社会心理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Apr 25 15:58:32 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769260, encodeId=ab871e692604b, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Fri Nov 13 11:58:32 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877329, encodeId=75a918e732931, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Tue Apr 27 02:58:32 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522462, encodeId=bba3152246298, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571222, encodeId=af6615e12224c, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617028, encodeId=cdfc161e028be, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887597, encodeId=615488e597a9, content=<a href='/topic/show?id=426b6109112' target=_blank style='color:#2F92EE;'>#术后管理#</a>应当重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61091, encryptionId=426b6109112, topicName=术后管理)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Sep 23 09:59:23 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887514, encodeId=74e988e514f6, content=对于接受双侧<a href='/topic/show?id=cb322362105' target=_blank style='color:#2F92EE;'>#乳房切除术#</a>的青年<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>患者,在术后身体功能、身体形象、性健康和焦虑状态异常的比例仍高于保乳手术和单侧乳房切除人群。因此,<a href='/topic/show?id=4bf12e14928' target=_blank style='color:#2F92EE;'>#保乳术#</a>仍然十分关键!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23621, encryptionId=cb322362105, topicName=乳房切除术), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌), TopicDto(id=27149, encryptionId=4bf12e14928, topicName=保乳术)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 22 22:07:17 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036277, encodeId=de7f10362e7be, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Sep 22 21:58:32 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1801498, encodeId=3392180149819, content=<a href='/topic/show?id=2dfae3977a2' target=_blank style='color:#2F92EE;'>#社会心理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73977, encryptionId=2dfae3977a2, topicName=社会心理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Apr 25 15:58:32 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769260, encodeId=ab871e692604b, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Fri Nov 13 11:58:32 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877329, encodeId=75a918e732931, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Tue Apr 27 02:58:32 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522462, encodeId=bba3152246298, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571222, encodeId=af6615e12224c, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617028, encodeId=cdfc161e028be, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887597, encodeId=615488e597a9, content=<a href='/topic/show?id=426b6109112' target=_blank style='color:#2F92EE;'>#术后管理#</a>应当重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61091, encryptionId=426b6109112, topicName=术后管理)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Sep 23 09:59:23 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887514, encodeId=74e988e514f6, content=对于接受双侧<a href='/topic/show?id=cb322362105' target=_blank style='color:#2F92EE;'>#乳房切除术#</a>的青年<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>患者,在术后身体功能、身体形象、性健康和焦虑状态异常的比例仍高于保乳手术和单侧乳房切除人群。因此,<a href='/topic/show?id=4bf12e14928' target=_blank style='color:#2F92EE;'>#保乳术#</a>仍然十分关键!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23621, encryptionId=cb322362105, topicName=乳房切除术), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌), TopicDto(id=27149, encryptionId=4bf12e14928, topicName=保乳术)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 22 22:07:17 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036277, encodeId=de7f10362e7be, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Sep 22 21:58:32 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1801498, encodeId=3392180149819, content=<a href='/topic/show?id=2dfae3977a2' target=_blank style='color:#2F92EE;'>#社会心理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73977, encryptionId=2dfae3977a2, topicName=社会心理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Apr 25 15:58:32 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769260, encodeId=ab871e692604b, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Fri Nov 13 11:58:32 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877329, encodeId=75a918e732931, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Tue Apr 27 02:58:32 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522462, encodeId=bba3152246298, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571222, encodeId=af6615e12224c, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617028, encodeId=cdfc161e028be, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887597, encodeId=615488e597a9, content=<a href='/topic/show?id=426b6109112' target=_blank style='color:#2F92EE;'>#术后管理#</a>应当重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61091, encryptionId=426b6109112, topicName=术后管理)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Sep 23 09:59:23 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887514, encodeId=74e988e514f6, content=对于接受双侧<a href='/topic/show?id=cb322362105' target=_blank style='color:#2F92EE;'>#乳房切除术#</a>的青年<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>患者,在术后身体功能、身体形象、性健康和焦虑状态异常的比例仍高于保乳手术和单侧乳房切除人群。因此,<a href='/topic/show?id=4bf12e14928' target=_blank style='color:#2F92EE;'>#保乳术#</a>仍然十分关键!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23621, encryptionId=cb322362105, topicName=乳房切除术), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌), TopicDto(id=27149, encryptionId=4bf12e14928, topicName=保乳术)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 22 22:07:17 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036277, encodeId=de7f10362e7be, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Sep 22 21:58:32 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1801498, encodeId=3392180149819, content=<a href='/topic/show?id=2dfae3977a2' target=_blank style='color:#2F92EE;'>#社会心理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73977, encryptionId=2dfae3977a2, topicName=社会心理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Apr 25 15:58:32 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769260, encodeId=ab871e692604b, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Fri Nov 13 11:58:32 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877329, encodeId=75a918e732931, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Tue Apr 27 02:58:32 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522462, encodeId=bba3152246298, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571222, encodeId=af6615e12224c, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617028, encodeId=cdfc161e028be, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887597, encodeId=615488e597a9, content=<a href='/topic/show?id=426b6109112' target=_blank style='color:#2F92EE;'>#术后管理#</a>应当重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61091, encryptionId=426b6109112, topicName=术后管理)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Sep 23 09:59:23 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887514, encodeId=74e988e514f6, content=对于接受双侧<a href='/topic/show?id=cb322362105' target=_blank style='color:#2F92EE;'>#乳房切除术#</a>的青年<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>患者,在术后身体功能、身体形象、性健康和焦虑状态异常的比例仍高于保乳手术和单侧乳房切除人群。因此,<a href='/topic/show?id=4bf12e14928' target=_blank style='color:#2F92EE;'>#保乳术#</a>仍然十分关键!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23621, encryptionId=cb322362105, topicName=乳房切除术), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌), TopicDto(id=27149, encryptionId=4bf12e14928, topicName=保乳术)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 22 22:07:17 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036277, encodeId=de7f10362e7be, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Sep 22 21:58:32 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1801498, encodeId=3392180149819, content=<a href='/topic/show?id=2dfae3977a2' target=_blank style='color:#2F92EE;'>#社会心理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73977, encryptionId=2dfae3977a2, topicName=社会心理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Apr 25 15:58:32 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769260, encodeId=ab871e692604b, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Fri Nov 13 11:58:32 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877329, encodeId=75a918e732931, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Tue Apr 27 02:58:32 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522462, encodeId=bba3152246298, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571222, encodeId=af6615e12224c, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617028, encodeId=cdfc161e028be, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887597, encodeId=615488e597a9, content=<a href='/topic/show?id=426b6109112' target=_blank style='color:#2F92EE;'>#术后管理#</a>应当重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61091, encryptionId=426b6109112, topicName=术后管理)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Sep 23 09:59:23 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887514, encodeId=74e988e514f6, content=对于接受双侧<a href='/topic/show?id=cb322362105' target=_blank style='color:#2F92EE;'>#乳房切除术#</a>的青年<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>患者,在术后身体功能、身体形象、性健康和焦虑状态异常的比例仍高于保乳手术和单侧乳房切除人群。因此,<a href='/topic/show?id=4bf12e14928' target=_blank style='color:#2F92EE;'>#保乳术#</a>仍然十分关键!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23621, encryptionId=cb322362105, topicName=乳房切除术), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌), TopicDto(id=27149, encryptionId=4bf12e14928, topicName=保乳术)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 22 22:07:17 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036277, encodeId=de7f10362e7be, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Sep 22 21:58:32 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1801498, encodeId=3392180149819, content=<a href='/topic/show?id=2dfae3977a2' target=_blank style='color:#2F92EE;'>#社会心理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73977, encryptionId=2dfae3977a2, topicName=社会心理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Apr 25 15:58:32 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769260, encodeId=ab871e692604b, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Fri Nov 13 11:58:32 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877329, encodeId=75a918e732931, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Tue Apr 27 02:58:32 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522462, encodeId=bba3152246298, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571222, encodeId=af6615e12224c, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617028, encodeId=cdfc161e028be, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887597, encodeId=615488e597a9, content=<a href='/topic/show?id=426b6109112' target=_blank style='color:#2F92EE;'>#术后管理#</a>应当重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61091, encryptionId=426b6109112, topicName=术后管理)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Sep 23 09:59:23 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887514, encodeId=74e988e514f6, content=对于接受双侧<a href='/topic/show?id=cb322362105' target=_blank style='color:#2F92EE;'>#乳房切除术#</a>的青年<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>患者,在术后身体功能、身体形象、性健康和焦虑状态异常的比例仍高于保乳手术和单侧乳房切除人群。因此,<a href='/topic/show?id=4bf12e14928' target=_blank style='color:#2F92EE;'>#保乳术#</a>仍然十分关键!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23621, encryptionId=cb322362105, topicName=乳房切除术), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌), TopicDto(id=27149, encryptionId=4bf12e14928, topicName=保乳术)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 22 22:07:17 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036277, encodeId=de7f10362e7be, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Sep 22 21:58:32 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
    2020-09-22 lovetcm

    对于接受双侧#乳房切除术#的青年#乳腺癌#患者,在术后身体功能、身体形象、性健康和焦虑状态异常的比例仍高于保乳手术和单侧乳房切除人群。因此,#保乳术#仍然十分关键!!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1801498, encodeId=3392180149819, content=<a href='/topic/show?id=2dfae3977a2' target=_blank style='color:#2F92EE;'>#社会心理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73977, encryptionId=2dfae3977a2, topicName=社会心理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sun Apr 25 15:58:32 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769260, encodeId=ab871e692604b, content=<a href='/topic/show?id=e392489653e' target=_blank style='color:#2F92EE;'>#年轻乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48965, encryptionId=e392489653e, topicName=年轻乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e12138003973, createdName=bshuang, createdTime=Fri Nov 13 11:58:32 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877329, encodeId=75a918e732931, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Tue Apr 27 02:58:32 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522462, encodeId=bba3152246298, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571222, encodeId=af6615e12224c, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617028, encodeId=cdfc161e028be, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Thu Sep 24 09:58:32 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887597, encodeId=615488e597a9, content=<a href='/topic/show?id=426b6109112' target=_blank style='color:#2F92EE;'>#术后管理#</a>应当重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61091, encryptionId=426b6109112, topicName=术后管理)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Sep 23 09:59:23 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887514, encodeId=74e988e514f6, content=对于接受双侧<a href='/topic/show?id=cb322362105' target=_blank style='color:#2F92EE;'>#乳房切除术#</a>的青年<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>患者,在术后身体功能、身体形象、性健康和焦虑状态异常的比例仍高于保乳手术和单侧乳房切除人群。因此,<a href='/topic/show?id=4bf12e14928' target=_blank style='color:#2F92EE;'>#保乳术#</a>仍然十分关键!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23621, encryptionId=cb322362105, topicName=乳房切除术), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌), TopicDto(id=27149, encryptionId=4bf12e14928, topicName=保乳术)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Sep 22 22:07:17 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036277, encodeId=de7f10362e7be, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Sep 22 21:58:32 CST 2020, time=2020-09-22, status=1, ipAttribution=)]
    2020-09-22 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

相关资讯

MEN1611治疗乳腺癌的剂量递增试验:结果喜人

MEN1611+曲妥珠单抗+/-氟维司群的组合已显示出可接受的耐受性,并且在剂量逐步上升阶段没有剂量限制性毒性。

Lancet oncol:循环肿瘤DNA分析足以指导乳腺癌靶向治疗!

循环肿瘤DNA(ctDNA)检测或许可为晚期癌症的基因组谱提供实时评估,且不需要重复进行肿瘤活检。本研究旨在评估ctDNA检测评估晚期乳腺癌的精确性,以及ctDNA检测筛选适合突变靶向治疗的患者的能力

Nature:科学家找到让癌细胞“消停”的关键——TRIM37或是细胞分裂的“变阻器”

人体内时刻有细胞在分裂,在这个过程中出现的不受控制的错误会助长遗传错误,并可能继续发展为癌细胞。自100多年前癌细胞被发现以来,科学家们一直尝试寻找能够消灭这些“有害”细胞、治愈癌症的方法。

Nat Commun:双重阻断CD47和HER2能消除乳腺癌细胞的放疗抗性

放疗(RT)相比于化疗具有相对较小的全身性副作用,且被应用于所有亚型乳腺癌(BC)的治疗。然而,由于潜在的肿瘤放疗抵抗,最终可能会导致患者肿瘤复发或转移。

国产曲妥珠单抗纳入上海医保,个人自付670元/瓶

近日,上海医保局发文,将复宏汉霖曲妥珠单抗注射液纳入本市医保,参保人员个人定额自负标准为670元/瓶(150mg)。

Br J Cancer:ER表达状态对BRCA2突变型乳腺癌预后的影响

既往研究显示,BRCA2突变携带者具有较高的终身罹患乳腺癌的风险。然而,目前尚不清楚BRCA2突变时如何影响患者的生存或者对治疗的反应。BRCA1突变携带者一般呈现为ER阴性乳腺癌,相反的,BRCA2